GSK analyst price targets, scored
Every published price target on GSK in the AnaChart record, 2012-08-13 to 2026-01-06, with whether the stock reached it, how many calendar days that took, and how far above or below the close each target sat when published.
Analysts covering GSK, by scored targets
| Analyst | Scored | Reached | Share | Mean days | Median move | Last action |
|---|---|---|---|---|---|---|
| James Gordon | 15 | 2 | 13.3% | 184 | -47.2% | 2026-01-06 |
| Laura Sutcliffe | 14 | 2 | 14.3% | 788 | -48.3% | 2022-07-20 |
| Emmanuel Papadakis | 8 | 0 | 0.0% | -50.5% | 2025-02-06 | |
| Mark Purcell | 7 | 1 | 14.3% | 105 | -46.3% | 2024-07-22 |
| Luisa Hector | 6 | 0 | 0.0% | -43.5% | 2023-02-10 | |
| Emily Field | 6 | 0 | 0.0% | -49.8% | 2024-11-08 | |
| Peter Welford | 5 | 5 | 100.0% | 296 | +6.0% | 2024-11-12 |
| Justin Smith | 4 | 4 | 100.0% | 390 | -32.0% | 2022-05-17 |
| Andrew Baum | 4 | 1 | 25.0% | 67 | -44.4% | 2024-02-13 |
| Graham Parry | 3 | 1 | 33.3% | 50 | +3.1% | 2022-12-05 |
| Richard Vosser | 3 | 0 | 0.0% | -51.3% | 2023-02-02 | |
| Andrew Jeffrey | 3 | 2 | 66.7% | 320 | -15.2% | 2020-05-13 |
| Eric LE Berrigaud | 3 | 0 | 0.0% | -45.9% | 2024-11-01 | |
| James Faucette | 2 | 1 | 50.0% | 1521 | -54.0% | 2018-11-08 |
| Arren Cyganovich | 2 | 0 | 0.0% | -88.3% | 2021-07-29 | |
| Steve Scala | 2 | 2 | 100.0% | 256 | +9.8% | 2019-09-03 |
| Kerry Holford | 2 | 1 | 50.0% | 179 | -11.3% | 2024-12-02 |
| Faham Baig | 1 | 0 | 0.0% | -45.5% | 2020-10-05 | |
| Graham Perry | 1 | 1 | 100.0% | 1 | +2.4% | 2022-12-05 |
| Dominic Lunn | 1 | 0 | 0.0% | -51.2% | 2021-10-26 | |
| Ashwin Shirvaikar | 1 | 0 | 0.0% | -81.5% | 2019-08-07 | |
| Elmar Kraus | 1 | 0 | 0.0% | -48.0% | 2022-02-11 | |
| Geoffrey Porges | 1 | 0 | 0.0% | +18.0% | 2021-03-23 | |
| Vincent Caintic | 1 | 0 | 0.0% | -85.1% | 2021-08-02 | |
| John Eade | 1 | 1 | 100.0% | 442 | +15.7% | 2024-07-16 |
| John Boris | 1 | 1 | 100.0% | 0 | +0.2% | 2018-12-13 |
| Jeffrey Holford | 1 | 1 | 100.0% | 2240 | -40.4% | 2016-07-14 |
| Keyur Parekh | 1 | 0 | 0.0% | -30.6% | 2023-02-24 | |
| James Schneider | 1 | 0 | 0.0% | -73.0% | 2018-11-07 | |
| Jason Kupferberg | 1 | 1 | 100.0% | 1536 | -37.0% | 2018-06-18 |
| Jeff Cantwell | 1 | 1 | 100.0% | 1515 | -27.3% | 2019-05-08 |
| Rajan Sharma | 1 | 1 | 100.0% | 518 | +6.8% | 2025-06-30 |
| Tien-tsin Huang | 1 | 0 | 0.0% | -57.2% | 2019-05-08 | |
| Peter Christiansen | 1 | 0 | 0.0% | -91.8% | 2020-05-13 | |
| Mark Palmer | 1 | 0 | 0.0% | -40.2% | 2018-11-06 | |
| Matt Howlett | 1 | 0 | 0.0% | -89.2% | 2020-11-06 | |
| Trung Huynh | 1 | 0 | 0.0% | -52.5% | 2021-04-15 | |
| Alistair Campbell | 0 | 0 | 2020-11-02 | |||
| JO Walton | 0 | 0 | 2024-07-08 | |||
| Mark Clark | 0 | 0 | 2013-05-28 | |||
| John Davis | 0 | 0 | 2019-08-08 | |||
| Michael Leuchten | 0 | 0 | 2025-10-27 | |||
| Richard Parkes | 0 | 0 | 2020-02-10 | |||
| Richard Purkiss | 0 | 0 | 2016-09-23 | |||
| Seamus Fernandez | 0 | 0 | 2024-10-31 | |||
| Steve Mcgarry | 0 | 0 | 2022-02-18 | |||
| Vincent Meunier | 0 | 0 | 2018-03-22 |
How the scoring works
Direction is the target against the raw close on the day it was published. A target is reached when the stock trades through it in that direction on any later day, with no time limit, tested against the raw daily high or low. Days to hit are calendar days to the first such day. Implied move is the nominal target against that same close, in percent, signed, so a target below the close shows as negative; the file carries it on every scored row and the median above is over all scored targets on GSK, reached or not. Targets are kept as printed and split-adjusted, with the ratio beside them. Rows are never restated.